TRIL - 2 Biotech Stocks with Jaw-Dropping Growth Potential
Biotech stocks have proven time and again to be outstanding growth vehicles for risk-tolerant investors. Underscoring this point, companies like Axsome Therapeutics, Immunomedics, and Novavax have each generated enormous returns on capital for investors within an exceedingly short period of time.
Which biotech stocks might be the next big gainers? While it's frankly impossible to predict the next Axsome, Immunomedics, or Novavax with any degree of certainty, the small-cap biotechs Sorrento Therapeutics (NASDAQ: SRNE) and Trillium Therapeutics (NASDAQ: TRIL) appear to have a real shot at following in their footsteps from a growth standpoint. Here's a brief overview of the potential risks and rewards associated with these two small-cap biotech stocks.
Image source: Getty Images.